Schedule 13G ownership disclosure

Nabriva Therapeutics AG

Security class unavailable

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
237,888
Percent of class
11.2400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-16-001144
Form type
SC 13G
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Mar 23, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub